Skip to Main Content
American Flag
MEMORIAL DAY API SALE

50% off your first year of Quiver API

...

Use Promo Code:

MEM50
American Flag
Legislation Search

H.R. 3747: Accelerating Access to Dementia and Alzheimer’s Provider Training Act

This bill, known as the Accelerating Access to Dementia and Alzheimer’s Provider Training Act (AADAPT Act), aims to enhance training and resources for healthcare professionals dealing with Alzheimer's disease and related dementias. Here are the key components of the bill:

1. Reauthorization of Project ECHO Grant Program

The bill proposes to reauthorize the Project ECHO (Extension for Community Healthcare Outcomes) Grant Program, which focuses on improving healthcare access and outcomes in underserved areas. It would establish grants specifically aimed at:

  • Disseminating knowledge regarding Alzheimer’s disease and related dementias.
  • Building the capacity of healthcare professionals to better manage these conditions.

2. Eligible Entities for Grants

The bill defines eligible entities that can apply for the grants as:

  • Entities that provide healthcare services in various underserved areas, such as rural or frontier regions.
  • Public or nonprofit organizations capable of leading training models for dementia care.

3. Grant Utilization

Within one year of the bill's enactment, the Secretary of Health and Human Services would award grants to eligible organizations to:

  • Evaluate and expand technology-enabled collaborative learning and training models for healthcare professionals.
  • Improve early diagnosis and quality care for Alzheimer’s disease and related dementias.

4. Definition of Eligible Healthcare Professionals

The bill specifies that eligible healthcare professionals are those who:

  • Provide primary care services in underserved areas.
  • Are licensed or certified according to relevant laws.

5. Applications and Reporting

Entities looking to receive grants must submit applications that include plans for assessing the impact of the training initiatives on patient outcomes. They must also ensure that grant funds complement, rather than replace, other funding sources.

Entities awarded grants must report their findings to the Advisory Council on Alzheimer’s Research, Care, and Services, and the Secretary will produce an updated report on the program's progress within four years of the bill's enactment.

6. Funding Authorization

The bill authorizes appropriations of:

  • $10 million per fiscal year for general grants from 2022 through 2032.
  • $1 million per fiscal year for grants specifically addressing Alzheimer's care from 2027 through 2032.

7. Impact on Healthcare Providers

The aim of the bill is to enhance the ability of healthcare providers to diagnose and care for individuals living with Alzheimer's and related dementias, thereby improving overall healthcare delivery in affected communities.

Relevant Companies

  • None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

81 bill sponsors

Actions

7 actions

Date Action
May. 21, 2026 Committee Consideration and Mark-up Session Held
May. 21, 2026 Ordered to be Reported by the Yeas and Nays: 48 - 0.
May. 13, 2026 Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.
May. 13, 2026 Subcommittee Consideration and Mark-up Session Held
Jun. 05, 2025 Introduced in House
Jun. 05, 2025 Referred to the House Committee on Energy and Commerce.
Jun. 05, 2025 Referred to the Subcommittee on Health.

Corporate Lobbying

1 company lobbying

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Sale $1,001 - $15,000
May 11, 2026 Apr 13, 2026 +1.83%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Sale $1,001 - $15,000
Mar 09, 2026 Feb 06, 2026 -11.15%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
BIIB logo
BIIB BIOGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Feb 13, 2026 Jan 30, 2026 +0.59%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2026 Jan 29, 2026 +3.25%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Sep 09, 2025 Aug 26, 2025 +27.22%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Sep 09, 2025 Aug 26, 2025 +27.22%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Sale $1,001 - $15,000
Jun 10, 2025 May 19, 2025 +25.44%
Congress pfp
Robert Bresnahan R / House
BIIB logo
BIIB BIOGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jun 09, 2025 May 15, 2025 +31.55%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 23, 2025 +25.86%
Congress pfp
Robert Bresnahan R / House
BIIB logo
BIIB BIOGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 +20.99%
Congress pfp
Robert Bresnahan R / House
BIIB logo
BIIB BIOGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 +10.49%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 25, 2025 +10.49%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB -BIOGEN INC. CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 +21.17%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB -BIOGEN INC. CMN
Sale $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 +14.03%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 15, 2024 -5.54%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB DC BIOGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -26.15%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Sale $1,001 - $15,000
Sep 06, 2024 Aug 05, 2024 -46.47%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 02, 2024 -45.60%
Congress pfp
Ro Khanna D / House
BIIB logo
BIIB BIOGEN INC. CMN
Purchase $1,001 - $15,000
Sep 06, 2024 Aug 02, 2024 -45.60%